Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we deliver exogenous artificially synthesized miRNA mimics to the kidney via tail vein injection of a nonviral vector and polyethylenimine nanoparticles in several kidney disease mouse models. This led to significant overexpression of target miRNA in the kidney, resulting in inhibited progression of kidney disease in several mouse models.

Abstract

microRNAs (miRNAs), small noncoding RNAs (21-25 bases) that are not translated into proteins, inhibit lots of target messenger RNAs (mRNAs) by destabilizing and inhibiting their translation in various kidney diseases. Therefore, alternation of miRNA expression by exogenous artificially synthesized miRNA mimics is a potentially useful treatment option for inhibiting the development of many kidney diseases. However, because serum RNAase immediately degrades systematically administered exogenous miRNA mimics in vivo, delivery of miRNA to the kidney remains a challenge. Therefore, vectors that can protect exogenous miRNA mimics from degradation by RNAase and significantly deliver them to the kidney are necessary. Many studies have used viral vectors to deliver exogenous miRNA mimics or inhibitors to the kidney. However, viral vectors may cause an interferon response and/or genetic instability. Therefore, the development of viral vectors is also a hurdle for the clinical use of exogenous miRNA mimics or inhibitors. To overcome these concerns regarding viral vectors, we developed a nonviral vector method to deliver miRNA mimics to the kidney using tail vein injection of polyethylenimine nanoparticles (PEI-NPs), which led to significant overexpression of target miRNAs in several mouse models of kidney disease.

Introduction

miRNAs, small noncoding RNAs (21-25 bases) that are not translated into proteins, inhibit lots of target messenger RNAs (mRNAs) by destabilizing them and inhibiting their translation in various kidney diseases1,2. Therefore, gene therapy employing exogenous artificially synthesized miRNA mimics or inhibitors is a potential new option for inhibiting the development of many kidney diseases3,4,5.

Despite the promise of miRNA mimics or inhibitors for gene therapy, delivery to target organs rema....

Protocol

All animal experimental protocols were approved by the animal ethics committee of Jichi Medical University and performed in accordance with Use and Care of Experimental Animals guidelines from the Jichi Medical University Guide for Laboratory Animals. Here, we demonstrated miRNA mimic delivery to the kidney resulting in its overexpression using UUO mice. This study was approved by the Ethics Committee of Jichi Medical University [Approval Nos. 19-12 for renal fibrosis, 17-024 for acute kidney infection (AKI), and 19-11 f.......

Representative Results

The target miRNAs for renal fibrosis, diabetic nephropathy, and AKI described below were selected based on the microarray, qRT-PCR, and/or database research for gene therapy applications. For further details, refer to the previous publications13,14,15.

Delivery and effects of miRNA-146a-5p-mimic using PEI-NPs in renal fibrosis mice13
Fluo.......

Discussion

Using the protocol presented in this manuscript, PEI-NPs can deliver miRNA mimics to the kidney to induce overexpression of target miRNAs, resulting in treatment effects in in vivo mouse models of several renal diseases, including renal fibrosis, diabetic kidney disease, and AKI.

The method to prepare the complex of PEI-NPs and miRNA mimic is very simple. The positively charged surface of PEI-NPs entraps the miRNA mimic when they are just mixed13,

Acknowledgements

This work was partially supported by JSPS KAKENHI (Grant No. 21K08233). We thank Edanz (https://jp.edanz.com/ac) for editing drafts of this manuscript.

....

Materials

NameCompanyCatalog NumberComments
4’,6-diamidino-2-phenylindole for staining to nucleusThermo Fisher ScientificD-1306
Buffer RPEQiagen79216Wash buffer 2
Buffer RWTQiagen1067933Wash buffer 1
Control-miRNA-mimic (artificially synthesized miRNA)Thermo Fisher ScientificNot assigned5’-UUCUCCGAACGUGUCACGUTT- 3’ (sense)
5’-ACGUGACACGUUCGGAGAATT-3′ (antisense)
Cy3-labeled double-strand oligonucleotidesTakara Bio Inc.MIR7900
Fluorescein-labeled Lotus tetragonolobus lectinVector Laboratories IncFL-1321
In vivo-jetPEIPolyplus101000021
MicroAmp Optical 96-well reaction plate for qRT-PCRThermo Fisher Scientific431681396-well reaction plate
MicroAmp Optical Adhesive FilmThermo Fisher Scientific4311971Adhesive film for 96-well reaction plate
miRNA-146a-5p mimic (artificially synthesized miRNA)Thermo Fisher ScientificNot assigned5’-UGAGAACUGAAUUCCAUGGGU
UT-3′ (sense) 5’-CCCAUGGAAUUCAGUUCUCAUU -3′ (antisense)
miRNA-146a-5p primerQiagenMS00001638Not available because Qiagen has changed qRT-PCR kits (from miScript miRNA PCR system to miRCURY LNA miRNA PCR System from May 2021)
miRNA-181b-5p mimic (artificially synthesized miRNA)Gene designNot assigned5’-AACAUUCAUUGCUGUCGGUGG
GUU-3’
miRNA-181b-5p primerQiagenMS00006083Not available because Qiagen has changed qRT-PCR kits (from miScript miRNA PCR system to miRCURY LNA miRNA PCR System from May 2021)
miRNA-5100-mimic (artificially synthesized miRNA)Gene designNot assigned5’-UCGAAUCCCAGCGGUGCCUCU -3′
miRNA-5100-primerQiagenMS00042952Not available because Qiagen has changed qRT-PCR kits (from miScript miRNA PCR system to miRCURY LNA miRNA PCR System from May 2021)
miRNeasy Mini kitQiagen217004Membrane anchored spin column in a 2.0-mL collection tube
miScript II RT kitQiagen218161Not available because Qiagen has changed qRT-PCR kits (from miScript miRNA PCR system to miRCURY LNA miRNA PCR System from May 2021)
miScript SYBR Green PCR kitQiagen218073Not available because Qiagen has changed qRT-PCR kits (from miScript miRNA PCR system to miRCURY LNA miRNA PCR System from May 2021)
QIA shredderQiagen79654Biopolymer spin columns in a 2.0-mL collection tube
QIAzol Lysis ReagentQiagen79306Phenol/guanidine-based lysis reagent
QuantStudio 12K Flex Flex Real-Time PCR systemThermo Fisher Scientific4472380Real-time PCR instrument
QuantStudio 12K Flex Software version 1.2.1.Thermo Fisher Scientific4472380Real-time PCR instrument software
RNase-free waterQiagen129112
RNU6-2 primerQiagenMS00033740Not available because Qiagen has changed qRT-PCR kits (from miScript miRNA PCR system to miRCURY LNA miRNA PCR System from May 2021)
Tissue-Tek OCT (Optimal Cutting Temperature Compound)Sakura Finetek Japan Co.,Ltd.Not assigned

References

  1. Mohr, A. M., Mott, J. L. Overview of microRNA biology. Seminars in Liver Disease. 35 (1), 3-11 (2015).
  2. Bushati, N., Cohen, S. M. microRNA functions. Annual Review of Cell and Developmental Biology. 23, 175-205 (2007).
  3. Simpson, K., Wonnacott, A., Fras....

Explore More Articles

MiRNA MimicPolyethylenimine NanoparticlesKidney DiseaseMouse ModelsFluorescent LabelingKidney PerfusionTissue EmbeddingCryosectioning

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved